A Study of Safety of Weekly Subcutaneous Pegzilarginase in Subjects With Arginase 1 Deficiency

Clinical trial NCT05676853 · TERMINATED

Trial details

NCT number: NCT05676853
Sponsor: Aeglea Biotherapeutics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Arginase I Deficiency Hyperargininemia

Start date: 2023-04-04
Primary completion: 2023-04-27
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.